134 related articles for article (PubMed ID: 33113412)
1. Design, synthesis and biological evaluation of novel 7H-benzo [c] [1, 3] dioxolo [4, 5-f] chromen-7-one derivatives with potential anti-tumor activity.
Zhou S; Huang G
Bioorg Chem; 2020 Dec; 105():104381. PubMed ID: 33113412
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-tumor activity of Fissitungfine B compounds.
Zhou S; Zhou X; Huang G
Chem Biol Drug Des; 2022 Sep; 100(3):305-312. PubMed ID: 35763543
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2H-chromen-2-one derivatives targeting ERα as anti-breast cancer agents.
Luo G; Chen M; Lyu W; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Jun; 27(12):2668-2673. PubMed ID: 28460819
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel 2,3-dihydrochromeno[3,4-d]imidazol-4(1H)-one derivatives as potent anticancer cell proliferation and migration agents.
Han X; Luo J; Wu F; Hou X; Yan G; Zhou M; Zhang M; Pu C; Li R
Eur J Med Chem; 2016 May; 114():232-43. PubMed ID: 26994691
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic evaluation of some new[1,3]dioxolo[4,5-g]chromen-8-one derivatives.
Alipour E; Mousavi Z; Safaei Z; Pordeli M; Safavi M; Firoozpour L; Mohammadhosseini N; Saeedi M; Ardestani SK; Shafiee A; Foroumadi A
Daru; 2014 May; 22(1):41. PubMed ID: 24887061
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel o-aminobenzamide derivatives as potential anti-gastric cancer agents in vitro and in vivo.
Feng Y; Lu Y; Li J; Zhang H; Li Z; Feng H; Deng X; Liu D; Shi T; Jiang W; He Y; Zhang J; Wang Z
Eur J Med Chem; 2022 Jan; 227():113888. PubMed ID: 34628244
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells.
He ZX; Huo JL; Gong YP; An Q; Zhang X; Qiao H; Yang FF; Zhang XH; Jiao LM; Liu HM; Ma LY; Zhao W
Eur J Med Chem; 2021 Jan; 210():112970. PubMed ID: 33153765
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 289. Design, synthesis, and anti-breast cancer activity in vivo of 4-amino-2H-benzo[h]chromen-2-one and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogues with improved water solubility.
Dong Y; Nakagawa-Goto K; Lai CY; Morris-Natschke SL; Bastow KF; Kim Y; Lee EY; Lee KH
J Nat Prod; 2012 Mar; 75(3):370-7. PubMed ID: 22304236
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors.
Zhang X; Huang H; Zhang Z; Yan J; Wu T; Yin W; Sun Y; Wang X; Gu Y; Zhao D; Cheng M
Eur J Med Chem; 2021 Aug; 220():113501. PubMed ID: 33945992
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of novel dithiocarbamate substituted chromones.
Huang W; Ding Y; Miao Y; Liu MZ; Li Y; Yang GF
Eur J Med Chem; 2009 Sep; 44(9):3687-96. PubMed ID: 19410339
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
[TBL] [Abstract][Full Text] [Related]
13. Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates bearing sulfonylpiperazine as antitumor inhibitors targeting PI3Kα.
Yin Y; Sha S; Wu X; Wang SF; Qiao F; Song ZC; Zhu HL
Eur J Med Chem; 2019 Nov; 182():111630. PubMed ID: 31446244
[TBL] [Abstract][Full Text] [Related]
14. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.
Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L
Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo.
Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
Eur J Med Chem; 2019 Nov; 182():111665. PubMed ID: 31494469
[TBL] [Abstract][Full Text] [Related]
16. 2,4-Diarylpyrano[3,2-c]chromen-5(4H)-ones as Antiproliferative Agents.
Kumar D; Malik F; Bedi PM; Jain S
Chem Pharm Bull (Tokyo); 2016; 64(5):399-409. PubMed ID: 27150472
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel 4-(pyrrolo[2,3-d]pyrimidine-4-yloxy)benzamide derivatives as potential antitumor agents.
Zhang J; Xiong H; Yang F; He J; Chen T; Fu D; Zheng P; Tang Q
Bioorg Med Chem Lett; 2021 Feb; 33():127740. PubMed ID: 33316412
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR studies of bis-chromenone derivatives for anti-proliferative activity against human cancer cells.
Venkateswararao E; Sharma VK; Manickam M; Yun J; Jung SH
Bioorg Med Chem Lett; 2014 Nov; 24(22):5256-9. PubMed ID: 25442319
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
20. Discovery of anilino-furo[2,3-d]pyrimidine derivatives as dual inhibitors of EGFR/HER2 tyrosine kinase and their anticancer activity.
Hossam M; Lasheen DS; Ismail NSM; Esmat A; Mansour AM; Singab ANB; Abouzid KAM
Eur J Med Chem; 2018 Jan; 144():330-348. PubMed ID: 29275232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]